The micronucleus assay in radiation accidents by Thierens, Hubert & Vral, Anne
260
R
e
se
A
r
c
H
 f
r
o
m
 A
n
Im
A
l
 T
e
st
In
g
 t
o
 C
l
In
Ic
A
l
 E
x
p
e
r
Ie
n
c
e
Ann Ist super sAnItà 2009 | Vol. 45, no. 3: 260-264
Summary. The cytokinesis-block micronucleus assay in peripheral blood lymphocytes is a standard-
ised and validated technique for biodosimetry. Automated scoring of micronuclei allows large scale 
applications as in population triage in case of radiation accidents or malevolent use of radioactive 
sources. The dose detection limit (95% confidence) of the micronucleus assay for individual dose 
assessment is restricted to 0.2 Gy but can be decreased to 0.1 Gy by scoring centromeres in micronu-
clei using fluorescence in situ hybridization (FISH). In the past the micronucleus assay was applied 
for a number of large scale biomonitoring studies of nuclear power plant workers and hospital 
workers. Baseline micronucleus frequencies depend strongly on age and gender. The assay was also 
already used for biodosimetry of radiation accidents. In a multiple endpoint biodosimetry study 
for dose assessment of a worker exposed accidentally in 2003 to X-rays, a good agreement was ob-
tained between dose estimates resulting from the micronucleus assay, the scoring of dicentrics and 
translocations. Automated scoring of micronuclei in combination with centromere signals, allowing 
systematic biodosimetry of exposed populations, remains a challenge for the future.
Key words: micronucleus assay, biodosimetry, radiation accidents.
 
Riassunto (Il test dei micronuclei negli incidenti radiologici). Il test dei micronuclei, basato sul blocco 
della citochinesi, effettuato su linfociti da sangue periferico, è una tecnica standardizzata e validata 
per la biodosimetria. Lo scoring automatico dei micronuclei permette applicazioni su larga scala 
come ad esempio il triage in caso di incidenti radiologici o di uso malevolo di sorgenti radioattive. Il 
limite di rivelazione (livello di confidenza 95%) del test dei micronuclei per la valutazione della dose 
individuale è limitato a 0.2 Gy, ma può essere significativamente ridotto (0.1 Gy) con lo scoring dei 
centromeri nei micronuclei usando la fluorescence in situ hybridization (FISH). Il test dei micronuclei 
è stato applicato in passato a un gran numero di studi di monitoraggio biologico di lavoratori di im-
pianti di produzione di energia nucleare e di operatori sanitari. Le frequenze di fondo di micronuclei 
dipendono fortemente dall’età e dal genere. Questo saggio è già stato usato per la biodosimetria di 
incidenti radiologici. In uno studio di biodosimetria su endpoint multipli per la valutazione della 
dose di un lavoratore esposto nel 2003 in modo accidentale a raggi X è stato raggiunto un buon ac-
cordo tra le stime di dose ottenute dal test dei micronuclei, lo scoring con dicentrici e le traslocazioni. 
Lo scoring automatizzato di micronuclei in combinazione con i segnali dei centromeri, che permet-
tono una biodosimetria sistematica delle popolazioni esposte, rimane una sfida per il futuro. 
Parole chiave: test dei micronuclei, biodosimetria, incidenti radiologici.
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 THE MICRONUClEUS ASSAy 
AS bIOlOGICAl DOSIMETRy TOOl
The in vitro cytokinesis-block micronucleus (CBMN) 
assay, developed by Fenech and Morley in 1985, is 
a reliable method to quantify chromosome break-
age and loss in nucleated cells [1, 2]. Micronuclei 
(MNi) can be the result of small acentric chromo-
some fragments that are not incorporated into the 
daughter nuclei during cell division. They are envel-
oped by a nuclear membrane and appear as small 
nuclei – micronuclei – in the cytoplasm outside the 
main daughter nuclei. They arise during exposure 
to various clastogenic agents and are the result of 
non- or misrepaired DNA double strand breaks. 
MNi can also contain whole chromosomes that lag 
behind at anaphase during nuclear division and by 
consequence are not incorporated in the main nu-
clei. These MNi arise during exposure to aneugenic 
agents and represent also the main fraction of spon-
taneously occurring MNi. In the CBMN assay the 
scoring of MNi is restricted to once-divided cells, 
which are recognised by their binucleate (BN) appear-
ance after inhibition of cytokinesis by cytochalasin B. 
This restriction prevents confounding effects caused by 
variable cell division kinetics [1]. In Figure 1 an exam-
ple is given of binucleate cells with and without a 
micronucleus.
Because of its good reliability and reproducibility, 
the CBMN assay has become one of the standard 
cytogenetic techniques for genetic toxicology testing 
in human and mammalian cells in general [3]. In the 
field of radiation protection, the CBMN assay for 
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peripheral blood lymphocytes (PBL) is an appro-
priate biological dosimetry tool to evaluate in vivo 
radiation exposure of occupational, medical and ac-
cidentally exposed individuals and to assess in vitro 
radiosensitivity and cancer susceptibility [4-19]. 
Many studies showed that the number of radiation 
induced MNi is strongly correlated with radiation 
dose and radiation quality [20-25].
AUTOMATED SCORING OF MNi
Compared to the dicentric assay, which is the stand-
ard technique for biological dosimetry [26], the easy 
and rapid scoring of MNi makes this method very 
attractive for 1) large scale assessment of genetic 
damage in radiation workers receiving a high radia-
tion burden and, 2) for population triage in case of 
large scale radiation accidents. Automation of the 
MN scoring further results in a more reproducible 
analysis of MN frequencies due to withdrawal of 
the subjective MN identification by technical staff. 
Several algorithms for automated image analysis of 
the CBMN assay were already developed in the nine-
ties [27, 28]. These systems however showed limita-
tions such as a relative high inaccuracy in classifica-
tion of the BN cells. More recently, new and better 
automated image analysis systems for the CBMN 
assay have been developed. The MN software mod-
ule for the Metafer 4, developed and commercial-
ised by Metasystems, identifies a BN cell by the oc-
currence of two similar nuclei, close to each other 
but completely separated. In a second step, MNi are 
counted in a circular area defined around the two 
nuclei of the BN cell [29, 30]. The system developed 
by Decordier et al. (2008) [31] for use in biomoni-
toring of in vivo exposure to mutagenic agents, uses 
a PathFinderTMCellscanTM capture station and two 
MN analysis workstations. This system identifies 
firstly the cytoplasm of cells, subsequently detects 
the number of nuclei in the cell thus allowing iden-
tification of BN cells and in a third step it scores the 
MNi. However, this system still requires visual vali-
dation and processes only 12 slides a day. The study 
performed recently by our research group [32], using 
the Metasystems software, demonstrates the suita-
bility and advantage of automated MN scoring for 
population triage in case of large scale radiation ac-
cidents, where it is important to distinguish severely 
exposed individuals (≥ 1 Gy), who require early 
medical follow up and treatment, from those less ex-
posed. In our study, the MN frequencies scored au-
tomatically were highly correlated with the manual 
MN scores (r2 = 0.917) and a visual validation was 
not needed [32]. The reference dose response curve 
obtained for automated MN scoring, based on MN 
data of 10 individuals, showed that the uncertainty 
on a dose determination of 1 Gy amounts to 0.25 
Gy. The 95% confidence intervals of the 0 Gy and 1 
Gy doses do not overlap. Accurate dose estimations 
were also achieved at the higher doses (2 and 3 Gy) 
investigated. 
In the study it was estimated that 2 technicians can 
process at least 60 blood samples (120 slides) in a 12 
hour shift [32]. The restriction here is the number 
of slides that can be scored automatically with a 
Metafer 4 system equipped with a slide feeder in 
one day. Automation of the MN scoring further of-
fers the advantage that, when different laboratories, 
equipped with a Metafer 4 platform, use the same 
fixation protocol and MN classifiers, very compa-
rable results can be obtained. Before the automated 
MN assay can be implemented as a triage tool, it 
should be further validated using data obtained in 
an international network setting.
THE MICRONUClEUS-CENTROMERE ASSAy
The sensitivity of the micronucleus assay is lim-
ited to 0.2 Gy. This is due to the relatively high and 
variable spontaneous MN yield that is an inherent 
shortcoming of the MN assay for low dose estima-
tion. It is well known that most of the radiation in-
duced MNi originate primarily from acentric frag-
ments while spontaneous MNi contain especially 
whole chromosomes. By using a pancentromeric 
probe and applying fluorescence in situ hybridization 
(FISH) one can distinguish between MNi contain-
ing acentric fragments and those containing whole 
chromosomes [6, 33-36]. By applying this method, 
the sensitivity of the MN assay can be substantially 
increased in the low dose range [6, 35]. In both stud-
ies, using the pancentromeric p82H probe, the ma-
jority of spontaneous MNi were centromere posi-
tive (MNCM+) (resp. 73 and 71%). Most radiation 
induced MNi were centromere negative (MNCM-) 
while the number of MNCM+ only showed a very 
small increase with dose (resp. 3.7 and 5.3 MNCM+ 
per Gy per 1000 BN cells). By manual scoring of 
MNCM- in 2000 BN cells a detection limit, at the 
95% confidence limit, of 0.1 Gy can be achieved. 
According to the results of Algunes et al. [36], this 
detection limit is even lower: 0.05Gy. The CBMN-
centromere assay requires more time (2000 BN cells 
in half  a day) and effort compared to the conven-
tional CBMN assay. The development of an au-
Fig. 1 | Example of binucleated cells without and with one mi-
cronucleus.
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tomated “CBMN-centromere” scoring procedure, 
which is under progress, will reduce scoring time. 
Such an automated CBMN-centromere assay will 
allow systematic biomonitoring of radiation work-
ers exposed to low doses. 
 APPlICATION OF THE MICRONUClEUS 
ASSAy FOR bIOMONITORING 
The micronucleus assay was validated as in vivo ra-
diation biomonitor by our research group in a study 
of patients treated with large field radiotherapy for 
cervical cancer or Hodgkin’s disease [4]. After this 
validation stage the micronucleus assay was applied 
for large scale biomonitoring of nuclear power plant 
(NPP) workers and hospital workers [5-9]. For the 
first study (1996) the CBMN assay with manual 
scoring of 1000 BN cells was used to assess genetic 
damage in 269 nuclear power plant workers exposed 
occupationally to accumulated doses ranging from 
10 to 248 mSv [5]. In the second study (1999) the 
MN-centromere assay was used to evaluate the clas-
togenic and aneuploidogenic actions of radiation 
in 111 radiation workers exposed to doses ranging 
from 10 to 104 mSv over the last ten years versus a 
matched control group of 104 members of admin-
istrative staff  [7]. The third population under study 
(2000) comprised 71 hospital workers, exposed to 
ionising radiation as doctors, technicians or nurs-
es of Departments of Radiology, Radiotherapy, 
Nuclear Medicine. Cytogenetic monitoring with the 
MN-centromere assay was performed for this popu-
lation versus a matched control group of nurses and 
doctors working in the Department of Pediatrics 
[8]. In the study of the year 2002 the application of 
the micronucleus assay as radiation susceptibility 
biomarker was investigated in a population of 99 
nuclear power plant workers [9]. 
These large scale studies led to a number of gen-
eral conclusions. The spontaneous micronucleus 
yield is increasing systematically with age. For a 
male population values of 0.35 MNi/year and 0.44 
MNi/year were obtained respectively in the NPP 
and hospital workers studies [5, 8]. These values are 
in agreement with the large scale study of Fenech 
of variables influencing baseline micronucleus fre-
quencies: 0.31 MNi/year [37]. For the female popu-
lation of the hospital worker study [8] an increase of 
0.58 MNi/year was found, again in agreement with 
Fenech: 0.52 MNi/year [37]. The increase is thus 
more prominent for a female population. Detection 
of centromeres showed that the age increase of base-
line MN frequencies can be attributed almost totally 
to centromere-positive MN reflecting an increased 
chromosome loss with age. The X-chromosome is 
almost completely responsible for this spontaneous-
ly occurring chromosome loss [38, 39]. This explains 
also the gender difference in spontaneous MN fre-
quencies observed in the performed studies: for a 
population with mean age 41.4 and 41.8 years the 
mean spontaneous MN frequency amounts to 16.4 
for males and 23.5 for females respectively. On the 
contrary the difference in centromere-negative MNi 
is not significant: 6.7 vs 7.7. In the performed stud-
ies a restricted number of individuals (about 1-2%) 
showed very high MN yields (40-70 MNi/1000 BN 
cells). Repeated sampling confirmed these high val-
ues. Centromere staining showed that the high MN 
yields are almost completely centromere-positive 
MNi. The studies performed by our research group 
could not demonstrate a clear smoking effect on the 
MN frequency. Literature data regarding this point 
are contradictory [40]. 
The monitoring studies of radiation workers al-
lowed to investigate the dependence of MNi of the 
accumulated dose over the 10 years preceding the 
venepuncture. In the first study (1996) a linear re-
gression of the individual micronucleus frequencies, 
corrected for the age effect, showed an increase of 
0.0175 MNi/mSv with Pearson correlation coeffi-
cient value of 0.10. Application of the micronucle-
us-centromere assay in the second study of radiation 
workers resulted in almost the same increase of MNi 
with dose, 0.025 MNi/mSv and demonstrated that 
this dose dependence is completely due to MNCM- 
pointing to the clastogenic action of ionising radia-
tion. Dose dependence of MNi in an occupational 
exposure setting was also studied by Vaglenov et al. 
[41]. They reported an increase of 0.03 MNi/mSv. 
Large scale biomonitoring studies show that the 
micronucleus assay is able to demonstrate genetic 
damage at population level for accumulated doses 
received occupationally exceeding 50 mSv.
 APPlICATION OF THE MICRONUClEUS 
ASSAy IN RADIATION ACCIDENTS
In Belgium the research group applies systemati-
cally the conventional micronucleus assay for work-
ers exceeding the 20 mSv dose limits, imposed legal-
ly for occupationally exposed workers. The prescrip-
tion for this examination is given by the occupation-
al medicine service of the worker, a blood sample is 
taken and sent to our department. The procedures 
followed for biological dosimetry in case of overex-
posures are described in detail in [10]. For the deter-
mination of the dose corresponding to the scored 
micronucleus frequency, YMN, the laboratory’s dose 
response curve with age dependent background lev-
el MNBG is used (YMN = MNBG + 49.946 10
-3D + 
41.402 10-3D2 with YMN the micronucleus frequency 
and D the dose). The α- and β-coefficients of this 
relation are derived from the dose response of the 
in vitro X-ray induced MNi averaged over 10 donors 
[42]. For a 40 year old worker MNBG is adopted 
to be 1.58 10-2 for males and 2.25 10-2 for females 
[8]. For the age dependence of MNBG values of 0.44 
MNi/y and 0.58 MNi/y are adopted for males and 
females respectively [8]. The determination of the 
dose range corresponding to the 95% confidence 
interval is based on the interindividual differences 
among 10 donors in dose response of the in vitro 
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radiation induced MNi, published earlier [42]. For 
the uncertainty on MNBG at the 95% confidence 
level (1.96 SD) for the reference age of 40 years a 
value of 1.19 10-2 is deduced from the data published 
earlier by adjusting the micronucleus data for the 
age dependence [8]. Combining the uncertainties on 
dose response and MNBG allows the determination 
of the minimal and maximal dose levels (95% confi-
dence limits) corresponding to the dose estimate de-
rived from YMN using the mean dose response, given 
above. The result of this analysis is depicted graphi-
cally in Figure 2. 
In 2003 this biological dosimetry protocol was 
applied for retrospective assessment of the dose 
received by a hospital worker exposed accidentally 
by a 50 kV contact radiotherapy X-ray device dur-
ing maintenance. A dose estimate of 0.73 Gy was 
obtained with 95% confidence limits 0.54-0.96 Gy. 
Scoring of dicentrics resulted in a dose estimate of 
0.62 Gy (range 0.45-0.90 Gy), in very good agree-
ment with the micronucleus assay dose. The skin 
injury at the back of the worker indicated that the 
worker accidental overexposure was a partial body 
irradiation. From the overdispersion of the dicen-
trics data we could deduce that a fraction of 49% 
of the body was irradiated. It was not possible to 
apply this type of analysis to the micronucleus assay 
data to determine the fraction of the body exposed 
as those data always display an overdispersion even 
in the case of a total body irradiation. To study the 
decrease of micronucleus frequency with time post-
exposure a second blood sampling was performed 
one year after the first one. MNi disappear with a 
half-time of 342 days, very close to the value of 377 
days, obtained for dicentrics. This result is in agree-
ment with the decline in the micronucleus frequency 
with post-irradiation time down to about 60% after 
1 year post-treatment, observed in radiotherapy pa-
tients [43].
CONClUSIONS
The CBMN assay is a valuable technique of bio-
logical dosimetry, thoroughly validated and stand-
ardized. In view of the reliable automated scoring, 
worked out recently, the assay is of special interest 
for large scale applications as population triage. 
Scoring of centromeres by FISH increases the sen-
sitivity significantly. Automated scoring of MNi 
in combination with centromere signals remains a 
challenge for the future.
Submitted on invitation.
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Fig. 2 | Dose range (Y-axis) according to the 95% confidence 
level corresponding to a dose estimate derived from MNi scored 
as described in present work (X-axis).
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